Editorial: Women in molecular and cellular oncology

Petranel T Ferrao; Laura Rosanò; Valeria Poli; Shilpa S Dhar; Ana Paula Lepique

doi:10.3389/fonc.2023.1257780

Editorial: Women in molecular and cellular oncology

Front Oncol. 2023 Sep 4:13:1257780. doi: 10.3389/fonc.2023.1257780. eCollection 2023.

Authors

Petranel T Ferrao^{1

2

3

4}, Laura Rosanò⁵, Valeria Poli⁶, Shilpa S Dhar⁷, Ana Paula Lepique⁸

Affiliations

¹ Independent Researcher, Adelaide, SA, Australia.
² Precision Medicine, South Australian Health and Medical Research Institute, North Terrace, Adelaide, SA, Australia.
³ Corpallium Pty Ltd, Adelaide, SA, Australia.
⁴ Plena Vitae Therapies Pty Ltd, Adelaide, SA, Australia.
⁵ Institute of Molecular Biology and Pathology, Consiglio Nazionale delle Ricerche (CNR), Rome, Italy.
⁶ Department of Molecular Biotechnology and Health Sciences, University of Turin, Torino, Italy.
⁷ Department of Molecular & Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States.
⁸ Department of Immunology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP, Brazil.

No abstract available

Keywords: STEMM; cancer; diversity; female leadership; gender equality; oncology clinical trials; treatment cross-resistance.

Publication types

Editorial

Grants and funding

LR is funded by AIRC IG 21327 and by Regione Lazio POR FESR Lazio 2014-2020 "Gruppi di Ricerca 2020" [grant ID A0375-2020-36596 ORGANOVA"]. AL is a Conselho Nacional de Desenvolvimento Científico e Tecnlógico fellow, 310154/2021-9. VP is funded by AIRC IG 24851, PNRRM4C2-Investimento 1.4-CN00000041 “Finanziato dall’Unione Europea-NextGenerationEU”. PF received funding from the National Health and Medical Research Council (NHMRC) of Australia (GNT1126048).